Morgan Stanley has asked investors not to make any fresh entry in MRNA stock citing potential downside in the short-term. Moderna is having a meeting with...
The Moderna vaccine trial involved about 30,000 participants and the interim analysis for the vaccine was based on 95 infections among the trial participants The stock...
Neueste Kommentare